Rare disease drug discovery: the technologies driving ‘orphan’ therapeutics forward
Rare diseases have long posed a challenge in the field of medicine. Limited treatment options and diagnostic hurdles mean patient prognosis is often not positive; however, some groundbreaking technologies are offering hope of treatment to the small number of people affected by these so-called ‘orphan’ diseases. This Rare Disease Day, we explore how innovations like AI and gene editing are changing the game in rare disease research by advancing drug discovery and development. Rare diseases, as you might expect, are incredibly uncommon, affecting fewer than one in 2000 people. They are often associated with impaired quality of life and reduced...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!